丹参
迷迭香酸
生物化学
磷酸化
生物
激酶
生物合成
水杨酸
蛋白激酶A
酶
抗氧化剂
医学
病理
中医药
替代医学
作者
Xuecui Yin,Shuang Liu,Yuhang Zhang,Wen Yang,Jun Bu,Bin Zhang,Juane Dong
摘要
Salvianolic acid is the main active component of Salvia miltiorrhiza and holds significant value in the clinical treatment of myocardial ischemia and hypoxia. Previous studies have shown that salicylic acid (SA) can significantly promote the accumulation of salvianolic acid, but its molecular mechanism remains incompletely understood. To reveal the molecular mechanism by which SA regulates salvianolic acid, this study treated transgenic hairy roots overexpressing mitogen-activated protein kinase 3 (SmMAPK3) with SA and demonstrated that SmMAPK3 is essential for SA-induced salvianolic acid biosynthesis, with this function relying on the kinase activity of SmMAPK3. Through yeast two-hybrid screening, Rosmarinic Acid Synthase 1 (SmRAS1) was identified as a direct interacting protein of SmMAPK3. In vitro kinase assays showed that SmMAPK3 can catalyse phosphorylation of SmRAS1 at the Ser178 site, a process critical for salvianolic acid biosynthesis. Further studies confirmed that SA promotes the interaction between SmMAPK3 and SmRAS1, activates the kinase activity of SmMAPK3, and enhances the phosphorylation level and protein stability of SmRAS1. Additionally, SA treatment significantly promoted salvianolic acid accumulation in transgenic hairy roots coexpressing SmRAS1 and SmMAPK3. This study elucidates the mechanism by which the SA-SmMAPK3-SmRAS1 signalling module regulates salvianolic acid biosynthesis through post-translational modification, providing new theoretical targets for metabolic engineering and yield improvement of S. miltiorrhiza.
科研通智能强力驱动
Strongly Powered by AbleSci AI